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Abstract 
 
Over-dispersed count data typically pose a challenge to analysis using standard statistical methods, 
particularly when evaluating the efficacy of an intervention through the observed effect on the 
mean. We outline a novel statistical method for analysing such data, along with a statistically 
coherent framework within which the observed efficacy is assigned one of four easily interpretable 
classifications relative to a target efficacy: “adequate”, “reduced”, “borderline” or “inconclusive”. 
We illustrate our approach by analysing the anthelmintic efficacy of mebendazole using a dataset of 
egg reduction rates relating to three intestinal parasites from a treatment arm of a randomised 
controlled trial involving 91 children on Pemba Island, Tanzania. Numerical validation of the type I 
error rates of the novel method indicate that it performs as well as the best existing 
computationally-simple method, but with the additional advantage of providing valid inference in 
the case of an observed efficacy of 100%. The framework and statistical analysis method presented 
also allow the required sample size of a prospective study to be determined via simulation. Both the 
framework and method presented have high potential utility within medical parasitology, as well as 
other fields where over-dispersed count datasets are commonplace. In order to facilitate the use of 
these methods within the wider medical community, user interfaces for both study planning and 
analysis of existing datasets are freely provided along with our open-source code via: 
http://www.fecrt.com/framework 
 
 
1.  Introduction 
 
Count distributions arise in a number of fields relevant to medicine, and typically present different 
challenges for analysis than those encountered with continuous distributions, particularly where the 
mean count is close to zero and the observations are over-dispersed compared to the Poisson 
distribution. One such challenge arises when assessing the effect of interventions for countable 
phenomena such as criminal activities 1,2, migraines 3, falls in elderly patients 4, seizures 5,6, MRI 
lesion counts 7 and intestinal parasites 8–10, where the latter are quantified using counts of parasite 
eggs in stool. We define the problem first in general terms, and then with a motivating example. 
 
Let µ1 and µ2 denote the mean of two over-dispersed count datasets representing the comparator and 
treatment group, respectively. The ratio of µ2 to µ1 is the parameter of interest when measuring the 
effect of an intervention evaluated against either an alternative treatment or an untreated control. 
We consider two common study designs: those comparing paired sets of observations from the 
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same individuals before and after treatment (paired data), and those comparing a single set of 
observations from individuals assigned to different treatment/control groups (unpaired data). In 
both of these cases, it is useful to compare r = 1 - µ2 / µ1 to a pre-specified target, but there is 
currently no clearly-justified statistical framework within which summary statistics and confidence 
intervals can be interpreted, except in the simplest case when testing that µ1≠ µ2 7,11,12. We note that 
our focus is fundamentally different from that of the standard hypothesis of equality; we aim to 
investigate simultaneously two related but distinct questions: 
 
1) Is r low enough to conclude that the intervention demonstrates evidenced inadequacy? 
2) Is r high enough to conclude that the intervention demonstrates evidenced adequacy? 
 
Our motivating example is the analysis of egg reduction rate data (ERR; also known as faecal egg 
count reduction or FECR) in order to evaluate the efficacy of an anthelmintic treatment against 
intestinal parasites. Such data is most frequently collected in a paired experimental design, but 
unpaired studies comparing randomised treatment/control groups are possible, and a combination 
of the two situations, whereby multiple treatment arms result in multiple paired datasets (one for 
each treatment arm), are also encountered e.g. 13,14. In the paired study design, pre-treatment stool 
samples are obtained from individuals enrolled in the study and the number of parasite eggs within 
a fixed volume of stool is enumerated. A number of days after the administration of an anthelmintic 
treatment, a post-treatment stool sample is obtained from each of the individuals, and the number of 
parasite eggs within a fixed quantity of stool is again enumerated 15. One statistic of interest is the 
ERR, which is defined as one minus the ratio of arithmetic means between the pre-treatment data 
(µ1) and post-treatment data (µ2), thus reflecting the average efficacy of the drug in these 
individuals. An alternative statistic of interest is the cure rate, although we consider only the ERR 
here because the cure rate is arguably less appropriate for assessing drug efficacy 9,16. Typically, the 
goal of quantifying the ERR is either to assess the efficacy of novel anthelminthic treatments or 
regimens 13, or to provide evidence for reduced efficacy compared to the published expected 
efficacy of the same drug in a naïve population, i.e. to determine if either anthelmintic resistance is 
present or the drugs being used are of poor quality 9,10,17. Although the World Health Organisation 
guidelines 18 only discuss the use of point estimates, the standard approach to analysis within the 
medical literature is to generate 95% confidence intervals for the drug efficacy using a non-
parametric bootstrap 13,19. In veterinary parasitology, a variety of parametric approximation methods 
are used, such as that given by Coles et al. 20 and later expanded by Pepper et al. 21, the method of 
Levecke et al. 10, and the method of Dobson et al. 22. However, only one of these methods can be 
used when the observed efficacy equals 100% due to the post-treatment mean and variance of zero. 
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Alternative methods have been suggested based on Markov chain Monte Carlo (MCMC) 23–26, but 
the correct use of such computationally intensive methods requires statistical and computational 
skills and training that may be out of scope for the typical practitioner 27.  
 
In addition to the lack of a standardised method to calculate 95% confidence intervals, there is also 
a current lack of consensus regarding the interpretation of results based on these confidence 
intervals. In a veterinary parasitology conference abstract, Pepper et al. 21 used a simulation study to 
explore different interpretations and concluded that there were a number of inadequacies in standard 
approaches, arising from the failure to quantify and incorporate uncertainty. They recommended 
using a test of inferiority, i.e. a one-sided test of r compared to a pre-specified target value. They 
also noted the importance of powering studies appropriately, given what they perceived as a low 
probability of detecting situations where the true efficacy was below the target. Accordingly, the 
same authors used a framework based on an inferiority test to interpret a simulation study 28. 
However, these studies are based on the empirical performance of different classification methods 
rather than a rigorous justification of the underlying statistical issues. To the authors’ knowledge, 
no such justification currently exists in either the medical or veterinary parasitology literature, or 
elsewhere within related fields. 
 
Our objective is therefore to outline and justify a statistical framework to evaluate the ratio of 
means between two data series drawn from negative binomial distributions. We implement this 
framework along with three currently available statistical tests, as well as two novel statistical 
methods, and compare the statistical properties of these methods by use of simulation. We illustrate 
our approach by analysing ERR data from one arm of a randomised controlled trial representing the 
efficacy of the anthelmintic mebendazole against three intestinal parasites in children; hookworm, 
Ascaris lumbricoides and Trichuris trichiura. 
 
 
2.  Data 
 
Our analytical methods are illustrated using a dataset obtained from a randomised controlled trial in 
children on Pemba Island, Tanzania, which is registered at ClinicalTrials.gov (NCT03245398) and 
has previously been described by Palmeirim et al. 14. The purpose of the original study was to 
compare single-dose and multiple-dose mebendazole treatment, but for the purposes of this 
manuscript, we only use data from the 91 individuals who completed the study according to the 
protocol for single-dose mebendazole treatment. Two stool samples were taken from each child on 
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different days, and were examined by preparing and screening duplicate Kato-Katz thick smears 29 
for each stool sample (each Kato-Katz thick smears represents approximately 41.7 mg of stool). 
The slides were examined under a light microscope and the total count over the four slides for each 
child was then recorded for the eggs of three parasites (hookworm, A. lumbricoides and T. 
trichiura). All 91 children were positive for hookworm at pre-treatment, 46 children were positive 
for A. lumbricoides, and 46 children were positive for T. trichiura. Each of the children was treated 
with the anthelmintic mebendazole before another two consecutive stool samples per subject were 
taken 14-21 days post-treatment and analysed as for the pre-treatment samples. This resulted in a 
total of 546 count observations from 91 individuals (two samples each relating to three parasites). 
Although Palmeirim et al. 14 reported data in terms of eggs per gram for each parasite (after 
multiplying observed counts by a constant of six), we have preserved the raw count observations for 
the purposes of this manuscript, and present mean values accordingly. Appropriate ERR targets for 
mebendazole for use with these parasites are given by the World Health Organisation 30; table A2.2 and 
Levecke et al. 10 as:  70% for hookworm, 95% for A. lumbricoides and 50% for T. trichiura. The 
objective of this exercise was to evaluate the observed efficacy of the drug by comparing the 
observed ERR to these published target figures, so that the evidence for reduced anthelmintic 
efficacy in this population can be assessed. 
 
 
3.  Statistical framework 
 
We propose a formal statistical framework that can be used to interpret the observed counts xi and yj 
in terms of the quantity of interest r = 1 - µ2 / µ1. Our example focuses on application to paired 
data, but we note that the framework also holds for use with unpaired data, either with treatment 
vs. control groups or with direct comparison between different treatment groups if the target 
efficacy is interpreted as the ratio of post-treatment mean counts between two treatment arms. If the 
purpose of the exercise is simply to establish estimates for r, then a straightforward point estimate 
and confidence interval associated with this estimator will suffice. However, we anticipate a further 
desire to classify the biological implications of the result according to a standardised interpretative 
framework illustrated by the two questions given in the introduction: 
 
1) Is r low enough to conclude that the intervention demonstrates evidenced inadequacy? 
2) Is r high enough to conclude that the intervention demonstrates evidenced adequacy? 
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We follow Pepper et al. 21 in suggesting that a one-sided inferiority test formulation is appropriate 
to address question (1), i.e. to assess whether there is statistically significant evidence that the 
observed mean efficacy is lower than desired. The most relevant location parameter against which 
to compare r for this purpose is a threshold TI equal to the expected efficacy E, e.g. 0.95 for A. 
lumbricoides. 
 
A test of superiority of the observed mean efficacy relative to an appropriate location parameter can 
be formulated in order to address question (2), although the authors are not aware of any previous 
study in which this has been done. In any case, we believe that a non-inferiority test is conceptually 
better justified. Such tests form part of the regulatory regime for producing generic pharmaceutical 
products, where it is necessary to show that the generics will not be appreciably worse than the 
original products 31–34 . We believe that there is a clear parallel between this situation and the desire 
to demonstrate that the efficacy of an anthelmintic compound observed ‘in the field’ is not 
appreciably worse than the expected efficacy of the same drug. Such a hypothesis requires the 
definition of an additional quantity: the margin of equivalence d, which quantifies the idea of ‘not 
appreciably worse’ as used above. We note that the margin of equivalence in a non-inferiority test 
can be made arbitrarily small; if the margin is set to zero, then the properties of the non-inferiority 
test will be identical to those of a test of superiority. The margin of equivalence d can usefully be 
defined as the difference between the target efficacy E and the maximum value for r that would be 
tolerated as consistent with an effective intervention. For example, if E is taken as 0.95 for A. 
lumbricoides and a non-inferiority threshold TA is defined as a minimum acceptable efficacy of 
0.90, then d = 0.05. In a situation where two drugs are to be compared directly by randomisation of 
individuals between the drugs, then the natural choice for the target E is a value of 0, reflecting an 
identical efficacy between drugs (so that the expected ratio µ2 / µ1 is equal to 1), and the choice of d 
follows the standard procedure for equivalence testing 34. 
 
Based on these two tests, and assuming that interpretation of the results will depend on the 
positioning of lower and upper confidence interval estimates for r obtained via some valid statistical 
method, it is straightforward and instructive to consider the different possible typologies that might 
arise in practice (Figure 1). There are ten different typologies in total, although these can be 
grouped into four typology groups based solely on the results of the two tests previously defined. It 
is important to note that previous interpretative approaches within the veterinary parasitology 
literature 20,25,28,35 have used the point estimate as part of the classification system (which would 
require us to provide an interpretation of each of the ten typologies), but we reject this strategy 
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Figure 1:  Possible typologies that result from assessing the position of the point estimate !̂ (red bar) 
and confidence intervals for r (red brackets), relative to the two thresholds TA (dashed line) and TI 
(solid line). Equivalent interpretations within typology groups are indicated using right braces. 
 
because it mixes two very different types of information relating to the population and the sample: 
the confidence interval, which quantifies uncertainty about the true underlying efficacy (population 
information), and the point estimate, which is simply a summary of what was observed in the study 
(sample information). For typologies 1a, 1b & 1c, the upper confidence bound for r is below the 
target TI , which is sufficient to conclude that the observed efficacy is statistically significantly 
inadequate, as defined previously. For typologies 4a, 4b & 4c, the lower confidence bound is above 
the target TA so we are able to conclude that r is statistically significantly adequate; typology 4c 
reflects the more extreme situation where r would be statistically significantly greater than the 
published naïve efficacy E, which may be unlikely to occur in practice. This illustrates the rationale 
behind using a non-inferiority hypothesis test within our framework; if a test of superiority were 
used instead, typology 4c would be the only situation in which the efficacy would be assessed as 
adequate. Typologies 2a, 2b & 2c reflect situations where the confidence interval for r is so wide 
that there is no evidence that the true value can be excluded from any of the parameter regions – a 
potential consequence of an inadequate sample size. Finally, typology 3 reflects a situation where 
there is statistically significant evidence that r lies between TA and TI, which can only occur when 
there is a sufficiently large sample size that the entire confidence interval is within these limits. The 
authors believe that it is appropriate for this typology to have a clear and distinct designation since, 
1)  Inferiority test
Upper confidence limit for r is below TI
Evidence for inadequate efficacy
Upper confidence limit for r is above TI
No evidence for inadequate efficacy
Upper confidence limit for r is below TI
Evidence for inadequate efficacy
Upper confidence limit for r is above TI
No evidence for inadequate efficacy
[ ]
TA TI
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
1a
1b
1c
2a
2b
2c
3
4a
4b
4c
2) Non-inferiority test
Lower confidence limit for r is below TA
No evidence for adequate efficacy
Lower confidence limit for r is below TA
No evidence for adequate efficacy
Lower confidence limit for r is above TA
Evidence for adequate efficacy
Lower confidence limit for r is above TA
Evidence for adequate efficacy
Typology
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should it arise in practice, this would reflect a very specific situation: where there is statistically 
significant evidence that the treatment has less efficacy than the target, but where it is also within 
the specified margin of equivalence. In our motivating example, this would correspond to a 
biological interpretation of early stage and/or low-level reduction in drug efficacy due to e.g. 
emerging anthelmintic resistance or sub-optimal drug quality. 
 
We also note that it is not necessary to know the precise estimates of the confidence intervals to 
classify to the four topologies; only the binary results of the two comparisons of lower CL ≥ TA and 
upper CL < TI. We can therefore define the classifications via one-sided hypothesis tests, as 
follows: 
 
1) Inferiority test:  there is evidence for reduced efficacy (r < E) if: 
a. Upper 95% CL < TI 
      Or, equivalently: 
b. We can reject the null hypothesis that ! ≥ $I with p < 0.025 
2) Non-inferiority test:  there is evidence for adequate efficacy (! ≥ % − ') if: 
a. Lower 95% CL ≥ TA 
      Or, equivalently: 
a. We can reject the null hypothesis that r < TA with p < 0.025 
 
Where only one of these two criteria are met, the result should be used to categorise the result as 
either adequate efficacy (typology 4) or reduced efficacy (typology 1), respectively. These 
classifications are based on positive evidence of either acceptable or reduced efficacy. Where 
neither criterion is met, the result should be categorised as inconclusive (typology 2) on the basis 
that there is insufficient evidence to conclude either that r ≥ TA or that r < TI. We follow Torgersen 
et al. 24 and Geurden et al. 25 in the use of this inconclusive categorisation, which we believe is 
valuable given that sufficient evidence for the positive classifications defined above is not always 
available in practice. Depending on the sample size and chosen value of d, it is also possible for 
both criteria to be met: a further category, borderline efficacy (typology 3), is therefore defined to 
describe situations where there is statistical evidence that !	is below the threshold TI but also above 
the threshold TA.  
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4.  Statistical methods 
 
4.1.  Notation and general remarks 
The following terms are used throughout this section: 
• efficacy:  In this manuscript the term efficacy is simply used as a synonym for the arithmetic 
mean egg reduction rate (ERR), although we note that the parasitological definition of 
anthelmintic efficacy is a more complex issue. 
• xi :  A set of pre-treatment count observations from individuals i in 1 … N1, distributed 
according to a negative binomial distribution with mean µ1 and shape parameter k1. 
• yj :  A set of post-treatment count observations from individuals j in 1 … N2, distributed 
according to a negative binomial distribution with mean µ2 and shape parameter k2. 
• paired data:  A study design where if i = j, the observations xi and yj will have been 
collected from the same individual. In this case, we assume that N1 = N2. 
• unpaired data:  A study design where an observation of any individual i is assumed to be 
independent of subsequent observations of all individuals j. In this case, we do not 
necessarily assume that N1 = N2. 
• r = 1 - µ2 / µ1 :  The quantity of interest, representing the efficacy (ERR) of the treatment. 
• !̂ = 1 − +,+- ∑ /01-02,∑ 341,42, = 1 − /53̅ :  The maximum likelihood estimator of r, which corresponds to 
the standard calculation of the arithmetic mean ERR. 
• 789 = 8+, ∑ :; = :̅+,;<8 	:  The maximum likelihood estimator of µ1 (and equivalently µ2). 
• E :  The target for r based on the expected effect of the intervention in optimal 
circumstances, which could be interpreted as full susceptibility to the anthelmintic 
compound, e.g. a target efficacy of 95% for A. lumbricoides would correspond to the 
expectation that µ2 ≤ (1-0.95)µ1 under a fully effective treatment. 
• d :  A non-inferiority margin below E indicating the minimum value of r that would be 
considered to be consistent with a fully efficacious intervention. 
• TI = E :  The inferiority test threshold. 
• TA = E-d :  The non-inferiority test threshold. 
 
A number of methods have previously been proposed to generate 95% confidence intervals for the 
ratio of means between two count distributions: we briefly outline these below for the case of 
paired data, therefore assuming that N = N1 = N2. For simplicity, we will also assume that a single 
pre-treatment count and a single post-treatment count are available for each individual, but we note 
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that each method can also be used after summing multiple pre-treatment and/or post-treatment 
observations for each individual. For example, where each xi consists of >8 replicate count 
observations within individual i (e.g. duplicate or quadruplicate Katz Katz thick smears), then 
summing these replicate observations within each xi results in a Negative Binomial distribution with 
mean equal to >8 ∙ 78 and an over-dispersion parameter equal to >8 ∙ @8 36. If each yj consists of >A 
replicate count observations within individual j, then these can be summed in a similar manner. The 
analysis can then be performed on the sums of these replicate observations, conditional on the 
number of replicates >8 being consistent across individuals i, and the number of replicates >A 
being consistent across individuals j. 
 
4.2. Existing computationally simple methods 
A normal approximation method is given in the appendix of Coles et al. 20 and later justified by 
Pepper et al. 21. Using our notation, the upper and lower 95% confidence limits for r are given by 100 ∙ C1 − D-D,E F±H√J  where  K = L,-+D, + L--+D- − A∙NOP,,-+D,D-   and t is the 97.5 percentile point for 
Student’s t distribution with degrees of freedom equal to R − 1. The confidence intervals are 
indeterminate when ∑ST = 0, and previous work has identified that egg count data in animals are 
not well approximated by a normal distribution 37, although the method has empirically been shown 
to work well within a relatively narrow range of parameter values when ∑ST > 0  23. We refer to this 
as the World Association for the Advancement of Veterinary Parasitology or WAAVP method. 
 
An alternative approximation based on the gamma distribution with parameters obtained using a 
delta method approximation is given by Levecke et al. 10. The upper and lower 95% confidence 
limits for r are given by the 2.5th and 97.5th quantiles of the gamma distribution with parameters 
V = (8XŶ)-J  and [ = J8XŶ , where K = 8+ CD-D,EA \L,-D,- + L--D-- − 2 ∙ ^_L,-L--D,D- ` and a represents the within-
individual correlation between pre- and post-treatment samples. We refer to this as the Gamma 
method. 
 
An exact Bayesian method based on conjugate priors has been proposed by Dobson et al. 22 based 
on the method of estimating confidence intervals for a binomial proportion given by Brown et al. 38. 
Assuming that yi ~ Binomial(xi, 1-r) then the beta distribution can be used as a conjugate prior to 
fully describe the posterior as: 
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(1 − !)	~BetagVh +iST+T<8 , [h + ji:;+;<8 k − \iST+T<8 	`l 
This method requires definition of the parameters α0 and β0 in the prior, for which Dobson et al. 22 
justify the use of values of 1 based on the empirical remark that it generates more conservative 
lower confidence intervals than the Jeffrey’s priors of 0.5 suggested by Brown et al. 38. This method 
ignores the correlation between paired :; and S;, and also assumes that the number of ‘trials’ is a 
fixed quantity, i.e. it does not model the potentially appreciable uncertainty in ∑:;. As a 
consequence, the confidence intervals generated are generally too narrow. Dobson et al. 22 note this 
based on empirical observations, and advocate the use of 99% confidence intervals in place of 95% 
confidence intervals to compensate for the effect. However, this method does not require that ∑ST >0, which is an important potential advantage. We refer to this as the Binomial method. 
 
4.3.  Asymptotic distribution of !̂ 
We note that the means of x and y will be asymptotically distributed as: m:̅S5n ≈ Normal uv 78(1 − !)78w , 1R 	xy 
Where: 
x = ⎣⎢⎢⎢
⎡78 + 78A@8 00 78 − !78 + (78 − !78)A@A ⎦⎥⎥
⎥⎤ 
 
Then, using the delta method 39, the maximum likelihood estimator for 1- r is asymptotically 
distributed as: 1 − !̂ ≈ Normal u1 − !, 1R ΔAy 
where, 
ΔA = m1 − !78 178n x Å	(1 − !) 78Ç1 78Ç 	É 
The matrix x can be estimated as: 
xÑ = ⎣⎢⎢
⎡ 1R − 1i (:; − :̅)A+;<8 00 1R − 1i (S; − S5)A+;<8 ⎦⎥⎥
⎤
 
and using maximum likelihood estimators for 1 − !̂ = S5 :̅Ç  and 78 = :̅, we obtain: 
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ΔAÖ = m1 − !̂:̅ 1:̅n xÑ Ü	(1 − !̂) :̅Ç1 :̅Ç 	á = u S5:̅AyA 1R − 1i (:; − :̅)A+;<8 + u1:̅yA 1R − 1i (S; − S5)A+;<8  
For paired data, it is also necessary to take account of the correlation between pre- and post-
treatment samples from the same individual. We do this by scaling the variance estimates 8+X8 ∑ (:; − :̅)A+;<8  and  8+X8 ∑ (S; − S5)A+;<8  by 1 minus the correlation between paired :; and S;. 
This allows for the calculation of asymptotically unbiased and efficient confidence intervals for r, 
but the estimates may be poor for small sample sizes. We refer to this as the Asymptotic method. 
 
4.4.  Exact distribution of an alternative test statistic 
Although r is typically the parameter of interest, the hypothesis testing framework allows us to 
consider any related test statistic for which the expected distribution under the null hypotheses can 
be defined. As such, we note that  ∑ àST − S5âA+-T<8 = 1 − !à	∑ (:; − :̅)A+,;<8 â is a potentially valid 
test statistic, and that: i ST+-T<8 ~	NegBin(RA@A, çA) 
where: çA = @A@A + (1 − !)78 
 
The quantities RA and r are fixed and defined by the null hypotheses, respectively. The quantities @A 
and 78 = @8 8Xé,é,  are unknown but can be estimated from the data. Following a similar rationale to 
that of Dobson et al. 22, we note that the Bayesian posterior distribution of p1 can be defined using a 
beta conjugate prior: 
ç8~Beta\Vh +i:;+,;<8 ,			[h + @8R8` 
Again, R8 is known, and the prior quantities α0 and β0 can be set to take small values, reflecting a 
minimally informative prior belief for the parameter ç8. By taking an indefinite integral of these 
two distributions, the expected distribution of the test statistic can be approximated using a beta 
negative binomial distribution: i ST+-T<8 ≈ BetaNegBin(VA,			[A,			RA@A) 
Where α2 and β2 can be calculated as non-linear functions of r, α0, β0, ∑ :;+,;<8 ,	R8, @8 and @A (see the 
statistical appendix for further details). For paired data, it is necessary to take account of the 
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correlation between pre- and post-treatment samples from the same individual. We do this by 
scaling the over-dispersion parameters @8	and @A by 1 minus the correlation between paired :; and S;. This method accounts for uncertainty in 78, but ignores uncertainty in @8 and @A, which are 
simply taken as point estimates from the data (we calculate these by maximum likelihood). The 
impact of assuming that  @8 and @A are fixed is assessed by simulation in section 6. Where @A 
cannot be estimated from the data (i.e. when ∑ ST+-T<8 = 0), then the additional simplifying 
assumption of @A = @8 can be made, which permits the use of this method in the important case that ∑ST = 0. We refer to this as the Beta Negative Binomial or BNB method. 
 
Unlike the other methods described above, the BNB method cannot be used to generate confidence 
intervals for r, but it can be used as the basis for hypothesis testing within the framework specified 
in section 3, given values of r against which to test the observed data. Specifically, the observed test 
statistic ∑ ST+-T<8  can be compared to the expected distribution of the test statistic under the null 
hypotheses of: 
 
1) One-sided inferiority test of evidence for reduced efficacy (r < E) 
H0:   r ≥ TI 
H1:   r < TI 
Where the associated p-value pI is defined as the probability of observing values of 
the test statistic ∑S that are greater than or equal to the observed ∑ ST+-T<8  under a 
beta negative binomial distribution with r = TI and other parameters as derived 
above. 
2) One-sided non-inferiority test of evidence for adequate efficacy (! ≥ % − ') 
H0:   r < TA 
H1:   r ≥ TA 
Where the associated p-value pA	is defined as the probability of observing values of 
the test statistic ∑S that are less than or equal to the observed ∑ ST+-T<8  under a beta 
negative binomial distribution with r = TA and other parameters as derived above. 
 
The classifications specified in section 3 can then be applied to the results of these p-values, with 
significance thresholds of p < 0.025 used here for equivalence with the use of 95% confidence 
intervals. This allows for comparison of the BNB method to the WAAVP, Gamma, Binomial and 
Asymptotic methods. 
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5.  Application 
5.1. Analysis methods 
Data derived from the three paired datasets described in section 2 were analysed using the five 
analytical methods described in section 4 (BNB, WAAVP, Gamma, Binomial, and Asymptotic). 
Mebendazole efficacy targets of 70% for hookworm, 95% for A. lumbricoides and 50% for T. 
trichiura were used, as recommended by the World Health Organisation 30. There is currently no 
standard recommendation for an appropriate non-inferiority margin for use with this anthelmintic, 
so we used an arbitrary value of 0.05 for consistency with efficacy threshold values previously 
recommended in the veterinary literature 20. However, a value of e.g. 0.1 is equally justifiable for 
situations where this would reflect the maximum reduction in efficacy that is clinically acceptable 
34. Depending on the analytical method, either p-values (for the BNB method) or 95% confidence 
intervals (for other methods) were used to generate a classification for the observed efficacy as 
previously described. 
 
5.2. Analysis results 
Estimated efficacies (defined here as arithmetic mean ERR) of 53%, 100% and 49% were 
calculated for hookworm, A. lumbricoides and T. trichiura, respectively. Estimates of the over-
dispersion parameters @8	and @A were generated for each dataset using maximum likelihood 
estimation. These estimates are given along with the pre- and post-treatment mean egg counts and 
the correlation between pre- and post-treatment counts in Table 1. 
 
Table 1:  Estimates of pre-treatment arithmetic mean, post-treatment arithmetic mean, pre- and post-
treatment over-dispersion parameters k1 and k2 and the correlation between pre- and post-treatment data for 
three intestinal parasites based on samples from 91 children from Pemba Island (Tanzania). These numbers 
are presented in terms of the raw total egg counts rather than eggs per gram as given by Palmeirim et al. 14. 
 Hookworm Ascaris lumbricoides Trichuris trichiura 
Pre-treatment mean 74 1,255 162 
Post-treatment mean 35 0 83 
k1 0.84 0.08 0.92 
k2 0.58 -- 0.53 
Correlation 0.65 -- 0.68 
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Results from the five analytical methods applied to the three datasets are shown in Table 2. All 
methods yielded a classification of reduced efficacy (typology 1) for hookworm: the observed 
efficacy of 53% being significantly less than the target value of 70%. Confidence intervals were 
also qualitatively similar between the methods producing 95% confidence intervals, with the 
exception of the Binomial method, which generates confidence intervals that are spuriously 
narrow 35. For A. lumbricoides, the WAAVP, Gamma and Asymptotic methods failed to calculate 
uncertainty due to the 100% observed reduction. The remaining BNB and Binomial methods both 
classified the efficacy as adequate (typology 4). For T. trichiura, the inconclusive classification was 
assigned using all but one of the methods: the observed efficacy of 49% being neither significantly 
lower than the target value of 50% nor significantly within the margin of equivalence (typology 2). 
The only exception was the Binomial method, which classified the efficacy as adequate, again 
reflecting that this approach overstates the statistical confidence.  
 
Table 2:  95% confidence limits (or p-values) and associated classifications produced by five methods of 
statistical analysis for the egg count reduction of three intestinal parasites based on samples from 91 children 
from Pemba Island (Tanzania). 
Statistical 
Method 
Hookworm 
[Observed: 53%] 
 [Target: 70%] 
Ascaris lumbricoides 
 [Observed: 100%] 
[Target: 95%] 
Trichuris trichiura 
[Observed: 49%] 
 [Target: 50%] 
Estimate Classification Estimate Classification Estimate Classification 
WAAVP 
LCL: 39% 
UCL: 63% 
Reduced 
LCL: -- 
UCL: -- 
NA: ∑ST = 0 LCL: 32% 
UCL: 61% 
Inconclusive 
Gamma 
LCL: 40% 
UCL: 64% 
Reduced 
LCL: -- 
UCL: -- 
NA: ∑ST = 0 LCL: 34% 
UCL: 62% 
Inconclusive 
Binomial 
LCL: 51% 
UCL: 54% 
Reduced 
LCL: 99% 
UCL: 
100% 
Adequate 
LCL: 48% 
UCL: 50% 
Adequate 
Asymptotic 
LCL: 44% 
UCL: 62% 
Reduced 
LCL: -- 
UCL: -- 
NA: ∑ST = 0 LCL: 42% 
UCL: 55% 
Inconclusive 
BNB 
pA =1.000 
pI <0.001 
Reduced 
pA <0.001 
pI I=1.000 
Adequate 
pA =0.261 
pI =0.394 
Inconclusive 
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6.  Numerical validation 
6.1. Validation Methods 
The five different statistical methods outlined in section 4 vary in terms of limitations and 
assumptions, but are sufficiently computationally simple that their relative performance can be 
assessed using a simulation study. It is therefore useful to undertake a short numerical validation of 
each of these methods with parameter values similar to those encountered in the example datasets in 
order to ascertain the type I and type II error rates for the inferiority and non-inferiority tests 
associated with each method. 
 
Over-dispersed count data were simulated from negative binomial distributions corresponding to 
the two pre- and post-treatment datasets for each of the three parasites, with simulation parameter 
values for pre-treatment mean count, k1, k2 and correlation between pre- and post-treatment counts 
as given in Table 1. The correlation was simulated by drawing bivariate gamma values using the 
method described by Nadarajah and Gupta 40, and subsequently simulating the observed counts 
using a Poisson variate based on these. It was not possible to calculate k2 or the correlation between 
paired :; and S; for A. lumbricoides due to the 100% observed reduction, so values of k2 = 0.64 k1 
and correlation = 0.67 were assumed based on estimates of k2 / k1 and correlation obtained from the 
other two species. A total of 10,000 replicate pre-treatment datasets were simulated for each 
parasite, each with corresponding post-treatment datasets using 1,001 different values of r in the set 
{0.000, 0.001, 0.002, … 0.998, 0.999, 1.000} to represent the full spectrum of possible comparative 
efficacy values. This exercise was repeated with sample sizes of N = 91 (to match the example 
dataset), as well as N = 20 and N = 1,000 for comparison. Each of these ~90 million datasets were 
then analysed with each of the five statistical methods. The frequencies of each individual 
hypothesis test result were retained along with classification frequencies for each combination of 
analysis method, simulated parasite parameters, r and sample size. Where a simulated reduction of 
100% was obtained, neither hypothesis was assumed to be rejected for the WAAVP, Gamma and 
Asymptotic methods. The code required to run these simulations, including both data simulation 
and statistical analysis methods, was implemented in C++ using an Rcpp interface 41 within the 
“bayescount” package for R 42. 
 
6.2. Validation Results 
Generation and analysis of the datasets took approximately 160 µs per N = 20 dataset, 660 µs per 
N = 91 dataset and 7 ms per N = 1,000 dataset on a five-year-old 3.5GHz Xeon-class workstation. 
Profiling of the relevant C++ code involved indicated that the majority of the time was used in 
simulating the datasets and re-estimating the over-dispersion parameters via maximum likelihood. 
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The most relevant type I error rates, given our assumed sample size of 91 at simulated efficacy 
values corresponding to TI (the infimum of the set {! ∈ ℝ	|	% ≥ ! ≥ 1}) for the inferiority test and 
TA (the supremum of the set {! ∈ ℝ	|	0 ≥ ! > % − '}) for the non-inferiority test, are given in 
Table 3. The notional 2.5% type I error rates were generally very similar across the BNB, WAAVP 
and Gamma methods, although the error rate of the Gamma method exceeded that of the other 
methods for the non-inferiority test with A. lumbricoides, and the error rate of the BNB method 
exceeded that of the other methods for the inferiority test with T. trichiura. However, the relatively 
high error rate associated with the inferiority test for A. lumbricoides is of particular concern for the 
WAAVP (9.7%), Gamma (8.1%) and BNB (9.4%) methods. The type I error rates of the 
Asymptotic and Binomial methods far exceeded the notional rate of 2.5% for all parasite/test 
combinations, up to a maximum of 46.9% for the Binomial method and 17% for the Asymptotic 
method. Examples of type II error rates for a sample size of 91 at selected efficacy values are given 
in Table 4. These efficacy values were chosen to correspond to TI for the non-inferiority test, 
reflecting the power to detect non-inferiority at a true efficacy equal to E, and the supremum of the 
set {! ∈ ℝ	|	0 ≥ ! > % − '} for the inferiority test. The type II error rates of the BNB, Gamma and 
WAAVP methods were again similar, although the Gamma and WAAVP methods had lower type 
II error rates for the non-inferiority test with A. lumbricoides. 
 
Table 3:  Type I error rates for each of the five statistical methods applied to simulated data with a sample 
size of N = 91, corresponding to estimated parameter values from egg reduction rates of three intestinal 
parasite species based on samples from 91 children from Pemba Island (Tanzania). The values of r chosen 
correspond to the infimum of the set {! ∈ ℝ	|	% ≥ ! ≥ 1}) for the inferiority test, and the supremum of the 
set {! ∈ ℝ	|	0 ≥ ! > % − '} for the non-inferiority test. 
Parasite species Test r WAAVP Gamma Binomial Asymptotic BNB 
Hookworm 
Inferiority 0.70 0.036 0.033 0.327 0.094 0.038 
Non-Inferiority 0.65 0.021 0.029 0.346 0.116 0.021 
A. lumbricoides 
Inferiority 0.95 0.097 0.081 0.460 0.170 0.094 
Non-Inferiority 0.90 0.024 0.053 0.469 0.167 0.014 
T. trichiura 
Inferiority 0.50 0.039 0.035 0.424 0.130 0.048 
Non-Inferiority 0.45 0.019 0.028 0.426 0.129 0.020 
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Table 4:  Type II error rates for each of the five statistical methods applied to simulated data with a sample 
size of N = 91, corresponding to estimated parameter values from egg reduction rates of three intestinal 
parasite species based on samples from 91 children from Pemba Island (Tanzania). The values of r chosen 
correspond to E for the non-inferiority test, and the supremum of the set {! ∈ ℝ	|	0 ≥ ! > % − '} for the 
inferiority test. 
Parasite species Test r WAAVP Gamma Binomial Asymptotic BNB 
Hookworm 
Inferiority 0.65 0.680 0.707 0.166 0.481 0.672 
Non-Inferiority 0.70 0.717 0.670 0.153 0.402 0.721 
A. lumbricoides 
Inferiority 0.90 0.416 0.489 0.062 0.324 0.440 
Non-Inferiority 0.95 0.242 0.177 0.019 0.083 0.342 
T. trichiura 
Inferiority 0.45 0.820 0.835 0.246 0.605 0.794 
Non-Inferiority 0.50 0.875 0.848 0.237 0.578 0.870 
 
All estimated type I and type II error rates for each hypothesis test, statistical method, sample size 
and simulated parasite are given in Figures S1-S4. The error rates were generally very similar 
between WAAVP, Gamma and BNB methods for all parasites and sample sizes, except for the 
simulated efficacy values close to 100%, where the BNB method had a clear advantage. At a 
sample size of 1,000, all type I error rates at the critical values fell within the range 1.4-3.1% for the 
BNB, WAAVP and Gamma methods, but for the Asymptotic method these were still around 10%, 
and for the Binomial method, all exceeded 30%. With a sample size of N = 20, the type I error rates 
were substantially above 2.5% at the critical values for all methods, except for the WAAVP and 
BNB methods for non-inferiority tests with hookworm and T. trichiura. 
 
As well as focusing on each of the two tests individually, it is also instructive to consider the 
expected frequency of obtaining each of the four main typologies. These are shown in Figure 2 for a 
sample size of N=91 over a range of relevant simulated efficacy values. As would be expected, 
typology 1 (reduced efficacy) is most frequently observed at relatively low values of r, reducing to 
a frequency consistent with a notional 2.5% type I error rate at r = TI. Conversely, typology 4 
(adequate efficacy) is most frequently observed at relatively high values of r, reducing to a 
frequency consistent with a notional 2.5% type I error rate at r = TA. Typology 2 (inconclusive) is 
most frequently observed for values of r within or near to the range between TI and TA. Typology 3 
(borderline efficacy) is only rarely observed due to consistently high type II error rates for both 
individual tests when $ï ≥ !̂ > $ñ (with the exception of the Binomial method, where typology 3 is 
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seen even at relatively small sample sizes due to the spuriously narrow confidence intervals 
associated with this method 35). However, typology 3 is observed more frequently than typology 2 
for all methods at the higher sample size of 1,000 (data not shown); the larger sample size reducing 
the width of the derived confidence interval and hence reducing the observed occurrence of the 
‘inconclusive’ typology. 
 
 
Figure 2:  Classification frequencies of the four main typology groups for each of the five statistical 
methods applied to simulated data with a sample size of N = 91, which corresponds to estimated 
parameter values from egg reduction rates of three intestinal parasite species in 91 children from 
Pemba Island (Tanzania). The values corresponding to simulated efficacy values (r) equal to TA and 
TI are shown using dashed and solid black vertical lines, respectively, and the x-axis is limited to ± 
10 percentage points of these values. The fraction of simulated datasets that could not be analysed 
using the WAAVP, Gamma and Asymptotic methods due to a 100% observed reduction are shown 
in orange (a thin vertical stripe close to r = 100%, visible only for Ascaris lumbricoides). 
Hookworm Ascaris Trichuris
W
AAVP
Gam
m
a
Binom
ial
Asym
ptotic
BNB
55 60 65 70 75 80 80 85 90 95 100 35 40 45 50 55 60
Simulated Efficacy (%)
Typology 1 (Reduced) Typology 2 (Inconclusive) Typology 3 (Borderline) Typology 4 (Adequate) Failed
Hypothesis testing for the ratio of negative binomial distributions 
	
	 20	
7.  Discussion 
 
This work provides a theoretically justified statistical framework within which to evaluate the ratio 
of means between two data series drawn from negative binomial distributions. Our motivating 
example is in the field of medical parasitology, and we illustrate our approach by analysing three 
ERR datasets from a single arm of a randomised controlled trial representing hookworm, A. 
lumbricoides and T. trichiura egg counts, with A. lumbricoides posing particular statistical 
challenges due to the observed reduction of 100%. In each case, our framework provides a clearly 
interpretable and clinically relevant classification for each of the datasets relative to a published 
target efficacy value. We therefore believe that this framework will be useful within the fields of 
both medical and veterinary parasitology, as well as other fields where over-dispersed count 
datasets are commonplace, e.g. occurrence of migraines 3, falls in elderly patients 4, and seizures 5,6.  
 
Although no similar classification framework currently exists within the medical parasitology 
literature, a classification framework with similar goals forms part of the current WAAVP 
guidelines for the detection of anthelmintic resistance in animals 20. It is instructive to briefly 
compare the typologies within the framework presented here to the WAAVP classification system, 
which is based on the three possible outcomes of ‘resistance present’, ‘resistance suspected’, or 
‘susceptible’. The key element of the Coles et al. 20 framework is whether the lower 95% 
confidence limit for the mean is less than a minimum efficacy value 35. If this is the case, then the 
treatment will be described as ‘resistance present’ if !̂ < E, or ‘resistance suspected’ if !̂ ≥ E. A 
lower confidence limit below this minimum efficacy value could reflect resistance, but it could also 
be driven simply by a small sample size: the strongest interpretation of such an event therefore 
ought to be that there is no evidence that the treatment is delivering an adequate efficacy. This is a 
much weaker statement than the recommended classification of the treatment as ‘resistance present’ 
or ‘resistance suspected’, and implies the potential for a great number of false positive conclusions 
of resistance within the existing literature. As the use of confidence intervals in this framework is 
not based on a meaningful hypothesis test, the conclusions are not well formulated and the 
interpretation is unclear. In contrast, one of the important features of the inferiority/non-inferiority 
framework presented here is the focus on establishing positive evidence for statements made about 
efficacy, and the explicit acknowledgment of uncertainty, particularly that arising from limited 
sample sizes. For the interested reader, an interactive tool to explore the consequences of this 
classification framework is provided at http://www.fecrt.com/framework 
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Our framework requires two estimates to inform the threshold values used:  the target efficacy E 
and a non-inferiority margin d. In the context of assessing anthelmintic efficacy, the former should 
be chosen to reflect the expected ERR associated with a population of parasites that are fully 
susceptible to the anthelmintic in question: we suggest that this value can be drawn from the 
literature in most cases. The non-inferiority margin should be chosen as the maximum clinically 
acceptable difference in efficacy from the target 34, which may vary between different situations and 
study objectives. In the context of ERR, a value of d = 0.1 rather than 0.05 is equally justifiable if 
based on suitable clinical reasoning. Another important aspect of non-inferiority testing as 
implemented in the medical domain is the choice of confidence level 43. Whereas traditional 
inferiority and superiority testing is typically carried out with a 5% significance level (95% 
confidence), non-inferiority testing is frequently carried out with alternative, lower confidence 
levels such as 90%. The decision to use smaller confidence limits reduces the threshold of evidence 
required to reject the null hypothesis and accept the non-inferiority of the treatment; this is 
particularly important where the margin of equivalence is relatively small. Although ERR results 
have so far been interpreted exclusively using 95% confidence intervals, there is no reason that this 
flexibility in choice of confidence level should not be utilised. The inter-relatedness of the 
simultaneous inferiority and non-inferiority tests as presented here also gives rise to an additional 
and related point of consideration: for the most relevant observed estimates of r, a statistically 
significant test result (and therefore potential for type I error) can only be observed from one of the 
two hypothesis tests at a time, i.e. either for the inferiority test when !̂ < $ï or the non-inferiority 
test when !̂ ≥ $ñ. If the parameter range $ï ≥ !̂ > $ñ (where there is some possibility of obtaining 
typology 3) is disregarded, these considerations imply that for the most relevant values of !, an 
alpha value of 5% corresponds to an overall type I error rate of 5%. This choice might therefore be 
more appropriate than the 2.5% value implied by the current standard use of 95% confidence 
intervals. Using a higher alpha value would lead to correspondingly higher power, which is of 
potentially considerable practical benefit. Further work to explore the implications of this would be 
beneficial: the use of a formal statistical framework such as the one proposed here would be a 
coherent basis on which to assess such proposals. 
 
In addition to facilitating the interpretation of results following analysis of existing data, the 
framework developed also allows for the type I and type II error rates of any (computationally 
simple) statistical method to be quickly and easily quantified. This has been utilised here to show 
that the Gamma, WAAVP and BNB methods of analysis have broadly equivalent type I and type II 
error rates for population parameter values relevant to the three datasets presented. However, the 
extremely high over-dispersion evident in the A. lumbricoides dataset results in estimated type I 
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error rates for the inferiority test using each of these methods that substantially exceed the notional 
2.5% values. An important exception to these similarities is seen when high simulated efficacy 
values are used, when the BNB method has a clear advantage due to its ability to meaningfully 
analyse datasets with a 100% observed reduction. The potential disadvantage of the BNB method is 
that it does not produce confidence intervals, although this is not necessarily a disadvantage if the 
aim is to classify the observed reduction in a manner similar to that presented here. The apparently 
good performance of the WAAVP and Gamma methods is perhaps surprising given that a normal 
approximation has previously been shown to be poor for egg count data 37, but we note that the 
relatively large sample size and pre-treatment mean egg counts of our example datasets are likely to 
favour these methods. We therefore recommend the use of either the Gamma, WAAVP or BNB 
method for analysing similar datasets, with the latter likely to be preferred for lower pre-treatment 
mean egg counts. Alternatively, a more computationally-intensive method such as MCMC could be 
used 23–25,44, although we note the relative difficulty in verifying the properties of statistical tests 
based on MCMC compared to those based on the computationally simpler methods presented here. 
For datasets with different expected parameter values, it would seem prudent to undertake a further 
simulation exercise to verify that the planned statistical method provides valid inference under these 
conditions: this is likely to be of particular concern for small datasets with relatively high over-
dispersion. We also recommend that any further development in statistical methods be verified 
using the same simulation methods based on parameters informed by similarly appropriate data 
sets. 
 
Although beyond the scope of this paper, a similar simulation approach could be utilised as an aid 
to designing a prospective study to help determine the appropriate sample size for a given set of 
parameter values. This aspect of study design is currently largely neglected within the parasitology 
community due to the lack of widely available methods, although simulation studies have 
previously been published for a given set of parameter values 8,21,23,35,45 and methods are available 
for testing that r > 0% 7,11,12. Where each of the two hypothesis tests are considered separately, the 
results could be interpreted as a standard analysis of statistical power. However, when combining 
the results of the two related hypothesis tests into a single typology classification, we suggest that 
something similar to the typology plot given in Figure 2 may be easier to interpret. Comparison of 
these plots, if calculated for different sample sizes and choices of alpha, would allow practitioners 
to determine the minimum sample size required for a sufficiently high probability of obtaining a 
non-inconclusive typology classification over the range of expected efficacy values that are relevant 
to their application, while controlling the risk of recording a misleading classification. Code to 
implement these sample size calculations is provided along with implementations of all the 
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statistical methods discussed here as part of the open-source bayescount package for R 42. In order 
to facilitate the use of these methods within the wider medical community, user interfaces for both 
study planning and analysis of existing datasets are provided along with the underlying R package 
via the following website:   http://www.fecrt.com/framework 
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Figure S1:  Estimated type I error rates (y-axis) for the inferiority test based on each of the five 
statistical methods with varying simulated efficacy values (r; x-axis) and sample sizes of N = 20, 
N = 91 and N = 1,000 (colours). Estimates were obtained by Monte Carlo estimation from 
simulated data corresponding to parameter values from egg reduction rates of three intestinal 
parasite species in 91 children from Pemba Island (Tanzania). The nominal 2.5% type I error rate 
applicable at r = TI (left boundary of the x-axis) is shown as a horizontal dashed line. 
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Figure S2:  Estimated type II error rates (y-axis) for the inferiority test based on each of the five 
statistical methods with varying simulated efficacy values (r; x-axis) and sample sizes of N = 20, 
N = 91 and N = 1,000 (colours). Estimates were obtained by Monte Carlo estimation from 
simulated data corresponding to parameter values from egg reduction rates of three intestinal 
parasite species in 91 children from Pemba Island (Tanzania). The value of r corresponding to E is 
shown as a vertical dashed line. 
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Figure S3:  Estimated type I error rates (y-axis) for the non-inferiority test based on each of the five 
statistical methods with varying simulated efficacy values (r; x-axis) and sample sizes of N = 20, 
N = 91 and N = 1,000 (colours). Estimates were obtained by Monte Carlo estimation from 
simulated data corresponding to parameter values from egg reduction rates of three intestinal 
parasite species in 91 children from Pemba Island (Tanzania). The nominal 2.5% type I error rate 
applicable at r = TA (right boundary of the x-axis) is shown as a horizontal dashed line. 
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Figure S4:  Estimated type II error rates (y-axis) for the non-inferiority test based on each of the 
five statistical methods with varying simulated efficacy values (r; x-axis) and sample sizes of 
N = 20, N = 91 and N = 1,000 (colours). Estimates were obtained by Monte Carlo estimation from 
simulated data corresponding to parameter values from egg reduction rates of three intestinal 
parasite species in 91 children from Pemba Island (Tanzania). The value of r corresponding to % −' is shown as a vertical dashed line. 
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Statistical Appendix 
 
This appendix contains the derivation of the beta negative binomial (BNB) method presented in    
“A hypothesis testing framework for the ratio of means of two negative binomial distributions: 
classifying the efficacy of anthelmintic treatment against intestinal parasites” by Denwood et al. 
  
Background 
The efficacy r, defined as the ratio of the means of the two count distributions xi and yi, is typically 
the statistic of interest. However, within a hypothesis testing framework, we may also usefully 
consider the distribution of a sufficient statistic for the mean of one of the count distributions 
integrated over all possible values of an equivalent statistic for the other count distribution. For this 
derivation, we assume that both count distributions xi and yi follow negative binomial distributions, 
and that the over-dispersion parameters k1 and k2 are either known or can be estimated from the 
data. We show here how a beta negative binomial compound distribution can be used to describe 
the distribution of yi under one or more null hypotheses, with parameters that can be derived from 
the observed data xi and given parameter values r, k1 and k2.  
 
Estimation of the expectation for µ2 
We use the formulation of the negative binomial distribution defined as the number of successes 
before a given number of failures, with probability of success p, which is generalised to allow any 
strictly positive value of number of failures. This has the same distribution function as a gamma-
Poisson distribution, with shape parameter k representing the number of failures, and mean number 
of successes given by µ	 = #$%&#	 . We assume that k1 and k2 are known, while we treat p1 as a random 
variable with properties depending on the observed xi. In the following, we use a Bayesian 
framework to fully describe the posterior distribution of p1 using a conjugate prior distribution. 
Specifically, we use a beta distribution as the conjugate prior for the negative binomial (given fixed 
k), with posterior parameters: 
'%~Beta(.%, 0%)													.% = .2 +456768% 													0% = 02 + 9: 
where α0 and β0 are the hyperparameters for the prior for parameter p1. This line of reasoning 
follows that of Dobson et al. 1, who use a beta distribution to derive the confidence interval for r 
based on the assumption that ∑ <6768% ~Binomial(∑ 56768% , 1 − D). 
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We can then derive the uncertainty distribution for the post-treatment probability of success p2 by 
treating it as a non-linear function of the beta-distributed pre-treatment probability of success p1. 
Expressing µ2 as a function of p1, k1, k2 and r, it can be seen that: EF = 'F9F1 − 'F = (1 − D)	E% = (1 − D) '%9%1 − '%. 
Rearranging yields p2 as a non-linear function g of p1, r, k1 and k2: 'F = H('%; 9%, 9F, D) = #J$J(%&K)#J$J(%&K)&#J$LM$L. 
There are two options to yield the full distribution of the uncertainty in p2 given the beta conjugate 
prior for p1 (and fixed k1, k2, r): 
1. Numerical integration based on a sample of realisations of p1 from Beta(α1, β1) with 
subsequent functional transformation, which yields a Monte Carlo approximation to the 
distribution of p2. 
2. Using an approximation based on the delta method to approximate the mean and variance of 
the non-linear, smooth transformation 'F = H('%; 9%, 9F, D), given the fixed values and the 
moments of the random variable p1. 
Given that the primary objective here is to provide a method of performing power calculations, we 
prefer the computationally simpler method (2), and give the derivation of this below. However, we 
acknowledge the utility of numerical integration methods, and have also used these to verify that 
the approximations required in the delta method are justified. 
 
Delta method approximation 
The mean of the distribution of H('%; 9%, 9F, D) conditional on the Beta(α1, β1) distribution of the 
random variable p1, is empirically well estimated by the first 2 terms of the Taylor series expansion: N('F) ≈ HPN('%)Q + 12HSSPN('%)Q ∙ N UP'% − N('%)QFV. 
The variance of H('%; 9%, 9F, D)	is less stable in estimation, but is empirically well approximated 
using the higher order Taylor series expansion given on page 11 of Cooch & White 2 as: WXD('F) ≈ HSPN('%)QF ∙ N UP'% − N('%)QFV 	+ 2HSPN('%)Q ∙ HSSPN('%)Q2 ∙ N UP'% − N('%)QYV+ ZHSSPN('%)QF4 + 2HSPN('%)Q ∙ HSSSPN('%)Q3! ^ ∙ N UP'% − N('%)Q_V
+ `2HSPN('%)Q ∙ HSSSSPN('%)Q4! + HSSPN('%)Q ∙ HSSSPN('%)Q3! a ∙ N UP'% − N('%)QbV. 
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The required 1st-4th partial derivatives of g with respect to p1 given fixed and strictly positive k1, k2, 
r can readily be derived as: c	Hc	'% = 9%9F(1 − D)P('% − 1)9F − '%9%(1 − D)QF cFHc	'%F = −29%9F(1 − D)	(9F − 9%(1 − D))P('% − 1)	9F − '%9%(1 − D)QY  cYHc	'%Y = 69%9F(1 − D)	(9F − 9%(1 − D))F('%9%(1 − D) − '%9F + 9F)_  c_Hc	'%_ = 249%9F(1 − D)	(9%(1 − D) − 9F)YP('% − 1)	9F − '%9%(1 − D)Qb  
 
The 2nd, 3rd, 4th and 5th central moments of p1 are required to estimate the variance of g(p1; k1, k2, r). 
These can be reformulated in terms of crude moments by expanding the binomial; for example, for 
a random variable e with mean E: N((e − E)Y) = N(eY) − 3EN(eF) + 2EY. 
Given that p1 is Beta(α1, β1) distributed, we have: N('%f) = g(hJMiJ) g(hJMf)g(hJ)g(hJMiJMf), 
which for integer v has a trivial closed form; for example, v = 3 gives: N('%Y) = g(hJMiJ)g(hJMY)g(hJ) g(hJMiJMY) = (hJMF)(hJM%)hJ(hJMiJMF)(hJMiJM%)(hJMiJ). 
 
All of the required quantities can therefore be easily calculated so that the mean and variance of the 
uncertainty distribution describing p2 (and therefore also that for ∑ <6jL68% ) can be derived. Although 
we have not defined the functional form of this distribution of uncertainty for p2, the distribution is 
bounded at [0, 1] and numerical integration of the transformation empirically approximates a beta 
distribution within sensible parameter bounds. We therefore describe the distribution of uncertainty 
for p2 using a Beta(α2, β2) distribution with parameters derived from the mean and variance of this 
distribution as defined above. 
 
Distribution of the test statistic 
In order to implement the statistical tests, a sufficient statistic derived from <6 must be compared to 
the distribution of the same statistic under the null hypothesis. We note that the sum of <6 is 
distributed according to: ∑ <6jL68% ∼ NegBin(nF9F, 'F). 
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The quantity N2k2 is assumed to be fixed, and p2 is described by a Beta(α2, β2) distribution, 
conditional on the observed xi, fixed quantities k1 and k2, prior parameters α0 and β0, and an 
assumed fixed value for the efficacy r that corresponds to the efficacy specified under the null 
hypothesis. We can therefore describe the expected distribution of the test statistic using a beta 
negative binomial distribution, defined as s successes before a given number of failures for 
consistency with our use of the negative binomial distribution, with probability mass function given 
by: '(o; αF, βF, nF9F) =	 Γ(nF9F + o)9! Γ(nF9F) B(βF + nF9F, αF + o)B(βF,, αF) , 
where B is the beta function. The observed test statistic ∑ <6jL68%  can be evaluated with respect to this 
beta negative binomial distribution to derive the associated p-value. 
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